Creyon: Creyon Bio gets some green for a new take on AI and genetic meds R&D
Creyon Bio is the latest company to launch with artificial intelligence technology for drug R&D. The startup claims it's technology can provide sufficient safety and toxicity to enable a therapy to bypass the animal research currently needed before clinical trials.
Read full article »
Creyon is a California-based preclinical stage company that researches and commercializes oligonucleotide medicines for the treatment of respiratory diseases.
Read more